Notably, tumors arising from mRas/mp53/wtEGFR over-expressing K5+/K19− cell line had a statistically significant longer latency and lower tumor incidence than those arising from other cell lines tested (Figure 5A, Supplementary Table 2). The gene discussed is KRT5; the disease is neoplasm.